Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Publication
- Publication Type
Articles 1 - 2 of 2
Full-Text Articles in Entire DC Network
Richmond Watts For Families: An Action Plan To Bring Multifamily Community Solar To The City Of Richmond, Daniel P. Rafferty
Richmond Watts For Families: An Action Plan To Bring Multifamily Community Solar To The City Of Richmond, Daniel P. Rafferty
Master of Urban and Regional Planning Capstone Projects
Seeking to advance community solar energy for multifamily residents within the City of Richmond, Virginia, the Richmond Watts for Families (WFF) is a plan to guide the city in developing robust multifamily community solar program(s). Community (shared) solar has emerged as an alternative approach to traditional rooftop solar energy by allowing customers to subscribe to a portion of a solar array that is shared among other subscribers, which has the opportunity to increase participation by marginalized communities and those currently without the financial or physical means to install solar This plan aids the city in implementing its recently adopted climate …
The Influence Of Flavor On The Abuse Liability Of A Heated Tobacco Product And Its Feasibility As A Menthol Cigarette Substitute, Augustus White
The Influence Of Flavor On The Abuse Liability Of A Heated Tobacco Product And Its Feasibility As A Menthol Cigarette Substitute, Augustus White
Theses and Dissertations
Heated Tobacco Products (HTPs) purport to expose people that use cigarettes to fewer of the harmful or potentially harmful constituents of tobacco while still delivering reinforcing amounts of nicotine (Auer, Concha-Lozano et al., 2017). An exemplar of the HTP class, IQOS, and its three varieties of “HeatSticks” have been authorized by the Food and Drug Administration (FDA) as “Modified Risk Tobacco Products” (MRTP). However, as the FDA is planning to ban menthol as a characterizing flavor in cigarettes, questions remain regarding whether characterizing flavors should be permitted in HTPs (FDA, 2022e). New evidence regarding HTP abuse liability (i.e., the likelihood …